Charles River Laboratories International Inc (NYSE: CRL) kicked off on Tuesday, up 3.86% from the previous trading day, before settling in for the closing price of $163.50. Over the past 52 weeks, CRL has traded in a range of $160.85-$275.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 12.20%. While this was happening, its average annual earnings per share was recorded -4.46%. With a float of $50.59 million, this company’s outstanding shares have now reached $51.13 million.
Considering the fact that the conglomerate employs 21800 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 33.71%, operating margin of 13.86%, and the pretax margin is 12.77%.
Charles River Laboratories International Inc (CRL) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Charles River Laboratories International Inc is 1.08%, while institutional ownership is 102.70%. The most recent insider transaction that took place on Nov 07 ’24, was worth 1,430,918. In this transaction Director of this company sold 6,621 shares at a rate of $216.12, taking the stock ownership to the 12,386 shares. Before that another transaction happened on Nov 07 ’24, when Company’s Director sold 1,000 for $216.50, making the entire transaction worth $216,500. This insider now owns 0 shares in total.
Charles River Laboratories International Inc (CRL) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -4.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.87% during the next five years compared to 14.84% growth over the previous five years of trading.
Charles River Laboratories International Inc (NYSE: CRL) Trading Performance Indicators
Take a look at Charles River Laboratories International Inc’s (CRL) current performance indicators. Last quarter, stock had a quick ratio of 1.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.14. Likewise, its price to free cash flow for the trailing twelve months is 15.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 8.10, a number that is poised to hit 2.54 in the next quarter and is forecasted to reach 10.02 in one year’s time.
Technical Analysis of Charles River Laboratories International Inc (CRL)
Compared to the last year’s volume of 1.05 million, its volume of 1.64 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 14.54%. Additionally, its Average True Range was 6.83.
During the past 100 days, Charles River Laboratories International Inc’s (CRL) raw stochastic average was set at 12.96%, which indicates a significant decrease from 27.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.95% in the past 14 days, which was higher than the 38.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $191.66, while its 200-day Moving Average is $206.39. Nevertheless, the first resistance level for the watch stands at $172.71 in the near term. At $175.60, the stock is likely to face the second major resistance level. The third major resistance level sits at $179.46. If the price goes on to break the first support level at $165.96, it is likely to go to the next support level at $162.10. Should the price break the second support level, the third support level stands at $159.21.
Charles River Laboratories International Inc (NYSE: CRL) Key Stats
The company with the Market Capitalisation of 8.68 billion has total of 51,136K Shares Outstanding. Its annual sales at the moment are 4,129 M in contrast with the sum of 474,620 K annual income. Company’s last quarter sales were recorded 1,010 M and last quarter income was 69,280 K.
